Zynex, Inc. said its board approved a stock back program for an additional $2 million of the company's common stock.
The Englewood, Colo.-based developer of electrotherapy medical devices said the program will begin May 14 and terminate May 13, 2019, or when the $2 million buyback limit is reached.
Zynex expects to finance the share buyback with existing cash balances.
The company had undertaken a buyback program from Dec. 6, 2017, through March 6. It repurchased 495,091 common shares.